does retatrutide cause cancer GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management GLP-1 weight-loss drugs are transforming
Description
Author: Prasenjit Naskar - M.Sc.
Optimal Gut Health: Our bundle combines the power of our 60 billion CFU probiotic with Digestive Enzymes to promote a balanced and healthy gut environment
Start your plan today!
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for weight loss, and supplements for heart health.
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
BOOST METABOLISM: Lemme Burn's Green Tea Extract (std
